#Icad 2015 skin#
This includes executing our strategy for the upcoming transition to a new CPT code for skin electronic brachytherapy that will be effective on Janua transition that we have been preparing for since the new code was established last year.
#Icad 2015 professional#
"While we do not have any definitive updates on reimbursement at this time, we are working with our customers, professional medical societies, and Medicare to obtain clarity with respect to reimbursement. "Our second quarter results reflect solid performance in our Cancer Detection business offset by uncertainty in our Therapy business related to a reimbursement change for the treatment of non-melanoma skin cancer in the United States," said Ken Ferry, Chief Executive Officer. Implemented initiatives to reduce expenses in response to the general uncertainty related to reimbursement for non-melanoma skin cancer treatment in the United States
Goodwill and long-lived non cash impairment of $27.4 million Non-GAAP adjusted EBITDA of $1.6 million, or 14.4% of revenue, up from 9.5% in Q2 2014 Gross margin of 70.7%, flat compared to Q2 2014 Total revenue of $11.1 million, an increase of 15.3% year-over-year
(Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three months and six months ended June 30, 2015.
0 kommentar(er)
